全球全基因組合成市場規模、佔有率、趨勢和成長分析報告（2026-2034）

全基因組合成市場預計將從 2025 年的 45.3 億美元成長到 2034 年的 175.2 億美元，2026 年至 2034 年的複合年成長率為 16.21%。

全球全基因組合成市場是合成生物學領域一個新興且快速發展的細分市場。該領域涉及人工構建完整的基因組，使研究人員能夠設計和創造具有特定特徵的生物體。 DNA合成技術的進步以及人們對基因工程在醫療保健、農業和工業生物技術應用方面日益成長的興趣，正在推動這一市場的發展。

關鍵促進因素包括對合成生物學解決方案日益成長的需求以及基因組研究經費的增加。製藥公司正在利用基因組合成進行藥物發現和疫苗開發。此外，設計用於生質燃料生產和環境應用的微生物的能力正在擴大市場的潛力。學術機構和研究組織在該領域的發展中也發揮著至關重要的作用。

隨著技術的普及和成本效益的提高，全基因組合成市場預計將迎來顯著成長。倫理考量和法律規範將在塑造市場格局中發揮關鍵作用。自動化和人工智慧驅動的設計工具的創新有望進一步提升其能力。隨著合成生物學的不斷發展，該市場有望改變許多產業。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球全基因組合成市場：依產品與服務分類

• 市場分析、洞察與預測
• 軟體服務
• 消耗品
• 裝置

第5章：全球全基因組合成市場：依應用領域分類

• 市場分析、洞察與預測
• 個人化醫療
• 農業生物技術
• 合成生物學
• 工業應用
• 其他用途

第6章：全球全基因組合成市場：依最終用戶分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 診斷檢查室
• 學術研究機構
• 受託研究機構（CRO）

第7章：全球全基因組合成市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Twist Bioscience Corporation
  • Integrated DNA Technologies
  • Thermo Fisher Scientific Inc
  • Ansa Biotechnologies Inc
  • GenScript Biotech Corporation
  • Eurofins Genomics India Pvt. Ltd
  • OriGene Technologies Inc
  • Icon Genetics GmbH
  • J. Craig Venter Institute
  • ATUM
  • Merck KGaA

The Whole Genome Synthesis Market size is expected to reach USD 17.52 Billion in 2034 from USD 4.53 Billion (2025) growing at a CAGR of 16.21% during 2026-2034.

The global whole genome synthesis market is an emerging and rapidly evolving sector within synthetic biology. It involves the artificial construction of entire genomes, enabling researchers to design and create organisms with specific characteristics. The market has gained momentum due to advancements in DNA synthesis technologies and increasing interest in genetic engineering for applications in healthcare, agriculture, and industrial biotechnology.

Major drivers include the growing demand for synthetic biology solutions and increased funding for genomic research. Pharmaceutical companies are leveraging genome synthesis for drug discovery and vaccine development. Additionally, the ability to engineer microorganisms for biofuel production and environmental applications is expanding market potential. Academic institutions and research organizations are also playing a key role in advancing this field.

Looking forward, the whole genome synthesis market is expected to witness substantial growth as technology becomes more accessible and cost-effective. Ethical considerations and regulatory frameworks will play an important role in shaping the market. Innovations in automation and AI-driven design tools will further enhance capabilities. As synthetic biology continues to advance, this market holds transformative potential across multiple industries.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product and Service

• Software & Service
• Consumable
• Instrument

By Application

• Personalized Medicine
• Agricultural Biotechnology
• Synthetic Biology
• Industrial Applications
• Other Applications

By End User

• Pharmaceutical & Biotechnology Companies
• Diagnostic Laboratories
• Academic & Research Institutes
• Contract Research Organizations (CROs)

COMPANIES PROFILED

• Twist Bioscience Corporation, Integrated DNA Technologies, Thermo Fisher Scientific Inc, Ansa Biotechnologies Inc, GenScript Biotech Corporation, Eurofins Genomics India Pvt Ltd, OriGene Technologies Inc, Icon Genetics GmbH, J Craig Venter Institute, ATUM, Merck KGaA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL WHOLE GENOME SYNTHESIS MARKET: BY PRODUCT AND SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product And Service
• 4.2. Software & Service Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Consumable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Instrument Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL WHOLE GENOME SYNTHESIS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Personalized Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Agricultural Biotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Synthetic Biology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Industrial Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL WHOLE GENOME SYNTHESIS MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Contract Research Organizations (CROs) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL WHOLE GENOME SYNTHESIS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product And Service
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product And Service
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product And Service
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product And Service
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product And Service
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL WHOLE GENOME SYNTHESIS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Twist Bioscience Corporation
  • 9.2.2 Integrated DNA Technologies
  • 9.2.3 Thermo Fisher Scientific Inc
  • 9.2.4 Ansa Biotechnologies Inc
  • 9.2.5 GenScript Biotech Corporation
  • 9.2.6 Eurofins Genomics India Pvt. Ltd
  • 9.2.7 OriGene Technologies Inc
  • 9.2.8 Icon Genetics GmbH
  • 9.2.9 J. Craig Venter Institute
  • 9.2.10 ATUM
  • 9.2.11 Merck KGaA